Clinical Trial Update: Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Travoprost 0.004% to Pilocarpine 1% in chronic angle-closure glaucoma completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angle-closure Glaucoma

Drugs mentioned

• Pilocarpine 1% (pilocarpine)
• Travoprost 0.004% (travoprost)

Snippet

Sponsor: Alcon Research | Conditions: Angle-closure Glaucoma | Phase 4 | Status: COMPLETED | Results posted: 2010-03-15